Adolescent characteristics at first visit, ART start, age 10 years, and last visit and cumulative incidence of outcomes (mortality, transferred out, LTFU), compared by CIG.

<p>Adolescent characteristics at first visit, ART start, age 10 years, and last visit and cumulative incidence of outcomes (mortality, transferred out, LTFU), compared by CIG.</p

Comparison by geographic region of characteristics at first visit, ART start, age 10 years, and last visit of adolescents living with perinatally acquired HIV.

<p>ART, antiretroviral therapy; IQR, interquartile range; S&SE Asia, South and Southeast Asia; WHO, World Health Organization.</p

Comparison by CIG of characteristics at first visit, ART start, age 10 years, and last visit of adolescents living with perinatally acquired HIV.

<p>ART, antiretroviral therapy; CIG, country income group; IQR, interquartile range; WHO, World Health Organization.</p

Flow diagram of inclusion of adolescents living with perinatally acquired HIV (<i>N</i> = 38,187).

<p>CIPHER, Collaborative Initiative for Paediatric HIV Education and Research.</p

Profile of geographic regions included in the CIPHER global cohort adolescent analysis (<i>N</i> = 38,187 adolescents).

<p>Profile of geographic regions included in the CIPHER global cohort adolescent analysis (<i>N</i> = 38,187 adolescents).</p